TNFRSF6B
Tumor necrosis factor receptor superfamily member 6B
Also known as: DcR3, M68, TNF6B_HUMAN, TR6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95407
- Gene
- TNFRSF6B
- Ensembl
- ENSG00000243509
- Chromosome
- 20
- Canonical length
- 300 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene belongs to the tumor necrosis factor receptor superfamily. The encoded protein is postulated to play a regulatory role in suppressing FasL- and LIGHT-mediated cell death. It acts as a decoy receptor that competes with death receptors for ligand binding. Over-expression of this gene has been noted in gastrointestinal tract tumors. Read-through transcription into this gene from the neighboring upstream gene, which encodes regulator of telomere elongation helicase 1 (RTEL1), generates a non-coding transcript. [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
300 residues, UniProt reviewed canonical sequence.
>O95407|TNFRSF6B
1 MRALEGPGLS LLCLVLALPA LLPVPAVRGV AETPTYPWRD AETGERLVCA QCPPGTFVQR
61 PCRRDSPTTC GPCPPRHYTQ FWNYLERCRY CNVLCGEREE EARACHATHN RACRCRTGFF
121 AHAGFCLEHA SCPPGAGVIA PGTPSQNTQC QPCPPGTFSA SSSSSEQCQP HRNCTALGLA
181 LNVPGSSSHD TLCTSCTGFP LSTRVPGAEE CERAVIDFVA FQDISIKRLQ RLLQALEAPE
241 GWGPTPRAGR AALQLKLRRR LTELLGAQDG ALLVRLLQAL RVARMPGLER SVRERFLPVHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFRSF6B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 53 nTPM
Expression across tissuesHPA
Tissue
- lung: 53 nTPM
- spleen: 40 nTPM
- spinal cord: 33 nTPM
- adipose tissue: 30 nTPM
- basal ganglia: 28 nTPM
- hippocampal formation: 28 nTPM
Single-cell type
- brain inhibitory neurons: 11 nCPM
- astrocytes: 8.5 nCPM
- brain excitatory neurons: 8.2 nCPM
- other brain neurons: 7.9 nCPM
- oligodendrocytes: 4.9 nCPM
- bergmann glia: 4.8 nCPM
Immune cell
- plasmacytoid DC: 22 nTPM
- non-classical monocyte: 1.3 nTPM
- naive CD4 T-cell: 0.4 nTPM
- intermediate monocyte: 0.3 nTPM
- naive CD8 T-cell: 0.3 nTPM
- T-reg: 0.1 nTPM
Brain region
- thalamus: 21 nTPM
- medulla oblongata: 19 nTPM
- pons: 17 nTPM
- hypothalamus: 17 nTPM
- spinal cord: 15 nTPM
- amygdala: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.77
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.3
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TNFR/NGFR cysteine-rich region
- Tumor necrosis factor receptor superfamily decoy receptor
- TNFR/NGFR cysteine-rich region
- Tumor necrosis factor receptor 6B, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNFRSF6B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFRSF6B as an antibody target. Whether an autoantibody or antibody against TNFRSF6B could matter depends on whether native TNFRSF6B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFRSF6B is annotated as secreted, so native TNFRSF6B circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label TNFRSF6B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...